More precise Cas9 variant
More specific CRISPR-Cas9 gene scissors makes genome editing even more precise
© Bratovic et al., 2020
In order for Cas9 to cut a DNA target, it needs to be directed to the target site by what is called a guide RNA. The guide RNA contains the complementary sequence to the DNA target site, working like a ZIP Code to guide Cas9 to its target. "Sometimes, however, Cas9 can also cut DNA sequences that are very similar to the actual target, known as off-targets," explains Emmanuelle Charpentier, director of the Max Planck Unit for the Science of Pathogens.
This undesired activity of CRISPR-Cas9 can lead to inaccuracies in genome editing. "An unintended cut at the wrong place in the human genome can have profound consequences. That is why we need a more specific system," says Michael Böttcher, Assistant Professor at the Medical Faculty of the Martin Luther University.
Scientists are therefore trying to optimize Cas9 specificity using different approaches. In the current study, the team of researchers from Berlin and Halle focused on an evolutionarily conserved domain of Cas9, known as bridge helix.
Amino acids form stable loop
The researchers found that the bridge helix plays a critical role in the mechanism by which Cas9 interacts with its guide RNA and DNA target site. They identified a group of amino acid residues that make contact with the phosphate backbone of the guide RNA, thereby facilitating the formation of a stable loop, which is essential for the activity of Cas9. In such a loop, the Cas9-bound guide RNA pairs with the complementary strand of the DNA target sequence while displacing the second DNA strand, thereby enabling Cas9 to cut both DNA strands.
The researchers generated new Cas9 variants by changing these amino acid residues and found that several variants cut much less frequently at off-target sites than the original Cas9 enzyme. They further show that one of the identified variants, called R63A/Q768A, increased the gene editing specificity of Cas9 also in human cells. "Our results provide a new basis for further optimization of CRISPR-Cas9. They demonstrate the need to gain more knowledge about the biochemistry of CRISPR-Cas systems to further improve them", says Charpentier.
Original publication
Bratovic M, Fonfara I et al.; "Bridge Helix Arginines Play a Critical Role in Cas9 Sensitivity to Mismatches"; Nat. Chem. Biol.; 2 March, 2020
Original publication
Bratovic M, Fonfara I et al.; "Bridge Helix Arginines Play a Critical Role in Cas9 Sensitivity to Mismatches"; Nat. Chem. Biol.; 2 March, 2020
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.